All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
Legislative and Policy Shifts Shaping Homeopathy
By Mark Land, M.S., RAC-US, AAHP President As we settle into 2025, opportunities should increase for natural products, including homeopathy, from a more favorable climate...
Health Care/OTC Legislative Issues: What’s in Store on Capitol Hill
By Pete Evich, Vice President, Van Scoyoc Associates President Trump's second administration is bringing rapid change to Washington. (See "Early Impact of the Trump Administration.")...
Early Impact of the Trump Administration
By Pete Evich, Vice President, Van Scoyoc Associates President Trump has been on the job for almost two months and the pace of his administration...
How Government Decisions Impact the Homeopathy Industry
Homeopathy, like all sectors of the healthcare industry, is subject to oversight and influence from various parts of the U.S. government. From Congress to regulatory...
Ensuring “Safety” Remains the Hallmark of Homeopathic OTCs
By Mark Land, M.S., RAC-US, AAHP President Monitoring and reporting on the safety of homeopathic drug products is a multifaceted undertaking that begins in the...
Potential Nitrosamine Impurities in Your Products?
By Robert Sven Jechlitschka, Director of Quality and Development, Schwabe Pharma México In September 2024, the Food and Drug Administration published a final guidance document...
Lowest Permissible Attenuation
By Eric L. Foxman, HPCUS Senior Scientist While many might be familiar with the nomenclature and concept of "First Safe Dilution" (FSD), the Homeopathic Pharmacopeia...
